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doi:10.1016/j.pedneo.2011.05.010Misalignment of lung vessels (MLV) with or without alveolar capillary dysplasia (ACD) is a rare
cause of idiopathic persistent pulmonary hypertension of the neonate. This report describes
a full-term infant with severe and intractable pulmonary hypertension. The patient’s condition
progressively deteriorated despite high-frequency oscillatory ventilation, infusion of magne-
sium sulfate, dopamine, and dobutamine to control blood pressure, and nitric oxide inhalation
therapy. The infant died at 5 days of age. The diagnosis of MLV with ACD was established by
autopsy. Histopathologic analysis revealed a failure of formation and an ingrowth of alveolar
capillaries, thickening of the alveolar walls, poor contact of capillaries with alveolar epithe-
lium, small intra-acinar muscularized arterioles, and anomalous pulmonary veins within
bronchovascular bundles. The low rate of diagnosis of MLV with or without ACD may be because
of the early high mortality rate or patchy involvement in some cases. Increasing awareness of
this clinical entity may prevent the use of costly, invasive, and probably ineffective proce-
dures. Short-term improvement after inhalation of nitric oxide does not lead to long-term
survival but merely provides time for potential lung transplantation.
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Misalignment of lung vessels 2331. Introduction
Persistent pulmonary hypertension of the neonate (PPHN) is
characterized by cyanosis and respiratory distress. It may
be idiopathic or a complication of neonatal cardiorespira-
tory disorders, including pneumonia, perinatal hypoxia,
pulmonary hypoplasia, meconium aspiration syndrome, or
hyaline membrane disease.1 Misalignment of lung vessels
(MLV) with or without alveolar capillary dysplasia (ACD)
may cause idiopathic PPHN.2e7 This report describes
a neonate with severe and intractable PPHN without any
other accompanying anomaly. Histopathologic analysis of
lung tissues confirmed the diagnosis of MLV and ACD.
2. Case Report
A full-term male infant was born to a 27-year-old primi-
gravida after an uneventful pregnancy. The infant was
delivered by cesarean section because of placental abrup-
tion and fetal distress. The birth body weight was 2860 g,
and Apgar scores were 5 and 7 at 1 minute and 5 minutes,
respectively. The patient developed increasing respiratory
distress and cyanosis soon after birth. Arterial blood gas
data were pH 7.157, PO2 49.4 mmHg, PCO2 52.9 mmHg, and
HCO3 18.8 while breathing 30% oxygen. At 1 hour of age, the
patient’s respiratory status deteriorated, with the devel-
opment of cyanosis and bradycardia. The infant was
intubated with mechanical support. Cardiopulmonary
resuscitation was performed because of desaturation and
bradycardia. Chest radiography revealed bilateral pneu-
mothorax and pneumomediastinum (Figure 1). Thor-
acocentesis was performed using angiocatheters. Antibiotic
therapy with intravenous ampicillin and cefotaxime was
administered. Septic work-up, including blood and cere-
brospinal fluid cultures, was negative for abnormalities.
Hypoxemia and acidosis persisted despite 100% oxygen
supplementation. Congenital heart disease or PPHN was
suspected. Two-dimensional echocardiography was per-
formed, showing dilatation of the right atrium and right
ventricle, main pulmonary artery dilatation, a large atrial
bidirectional shunt through the patent foramen ovale, andFigure 1 Chest radiography showed bilateral pneumothorax
and pneumomediastinum.a large right-to-left shunt through a large patent ductus
arteriosus, with a pressure gradient of up to 35 mmHg. For
evaluation of the severity of pulmonary hypertension, the
right ventricular pre-ejection period to right ventricular
ejection time (RVPEP/RVET) ratio was measured by M
mode of echocardiography.8 According to the relationship
between the RVPEP/RVET ratio and pulmonary artery end
diastolic pressure (PAEDP), the normal range of RVPEP/
RVET ratio is less than 0.3, which indicates that the PAEDP
ranges from 10 mmHg to 15 mmHg. In patients with
pulmonary hypertension, the ratio may increase up to 0.35,
which corresponds to the PAEDP being higher than
20 mmHg. In this patient, the RVPEP/RVET ratio was 0.5,
which showed that the PAEDP was increasing definitely. All
of these findings indicated suprasystemic pulmonary blood
pressure. The patient’s condition progressively deterio-
rated inspite of aggressive treatment for severe persistent
pulmonary hypertension, including 100% oxygen supple-
mentation, high-frequency oscillatory ventilation, infusion
of magnesium sulfate, dopamine, and dobutamine to
control blood pressure, and inhaled nitric oxide therapy.
The infant died at age 5 days. With high awareness of the
possibility of MLV and ACD, autopsy was performed after
the parents provided informed consent. The heart and lung
structures were unremarkable grossly except for right
ventricle hypertrophy, patent foramen ovale, patent
ductus arteriosus, and dilatation of the pulmonary trunk.
Histopathologic analysis revealed a failure of formation
and an ingrowth of alveolar capillaries, thickening of the
alveolar walls, poor contact of capillaries with alveolar
epithelium, small intra-acinar muscularized arterioles, and
anomalous pulmonary veins within bronchovascular bundles
(Figure 2).3. Discussion
PPHN is characterized by a persistent right-to-left shunt
causing severe hypoxemia. The estimated annual incidence
is about 1 in 1000 live births.1 An overall mortality rate of
27.6% in Taiwan has been reported in the literature.9 MLV
and ACD are rare causes of PPHN, with a poor prognosis and
mortality rate in infancy of almost 100%.2e5 In this case, the
diagnosis of MLV and ACD was established by autopsy
findings.
MLV with or without ACD is a developmental disorder of
lung vessels.2e4 It was first described in 1981 by Janney et
al, who noted that “failure of the formation and ingrowth
of alveolar capillaries led to absence of normal air-blood
barriers” and “anomalous veins were present in the bron-
chovascular bundles.”2 More than 80 pediatric cases and 1
adult case have been reported in the English-language
literature.10 Al-Hathlol et al indicated a male predomi-
nance, with a male-to-female ratio of 3:2.11 Most of the
cases have been sporadic; about 10 familial cases (12% of
cases) have been described, suggesting an autosomal
recessive inheritance.5,6,10e15 In the literature, chromo-
somal analysis was performed in three cases, which showed
a normal karyotype.5,16,17 Using array comparative genomic
hybridization analysis, Stankiewicz et al demonstrated six
overlapping microdeletions encompassing the FOX tran-
scription factor gene cluster in chromosome 16q24.1q24.2
Figure 2 Photomicrograph shows alveolar capillary dysplasia and misalignment of lung vessels. (A) Alveoli septa (arrow) are
widened, with large centrally located venules surrounded by loose mesenchyme, haematoxylin and eosin stain, 40 original
magnification. (B) The alveolar septa show poor capillaries apposition and density, staining by CD31 immunohistochemistry stain,
100 original magnification. (C,D) Anomalous pulmonary veins (v) within the adventitia of pulmonary arteries (a) and bronchioli (b),
staining by (C) haematoxylin and eosin stain and (D) Masson’s trichrome stain, 100 original magnification.
234 S.-P. Hung et al
Misalignment of lung vessels 235in patients with ACD, MLV, and multiple congenital anom-
alies. Inactivating mutations of FOXF1 gene were also
reported.18
Clinical manifestations of this disorder are typically
severe and intractable PPHN, respiratory distress, and
cyanosis, followed by progressive respiratory failure. In
most cases, symptom onset is within 48 hours of birth,
although a few cases had a late onset of 2e7 weeks of age
and one reported case was diagnosed in an adult.10,12,19,20
Of cases affecting infants, 95% were full-term with appro-
priate size for gestational age.11 About half of the patients
had accompanying anomalies, including those of the
gastrointestinal tract, the genitourinary tract, and the
cardiovascular system.21e27 The frequencies of these
accompanying anomalies were 40%, 32%, and 16%, respec-
tively.11 Other rare associations have also been reported,
such as anterior segment dysgenesis of the eyes, hemi-
vertebrae, and phocomelia.5,22,24 Chest radiography is
usually nonspecific, although in some reported cases it has
revealed pneumothorax.2,5,6,14,17,21,25,28 Diagnosis is
confirmed by autopsy or lung biopsy.15,19,22e24,29,30 Usually,
the lung structure is gross, with some cases featuring
abnormal lobation.5,13,21,23 Histopathologic analysis of MLV
has revealed that anomalous pulmonary veins within the
bronchovascular sheath parallel to the pulmonary arteries
and bronchi, ACD present as absence or decrease of capil-
laries adjacent to alveolar epithelium, thickening of the
alveolar septum and medial hypertrophy of the small
pulmonary arteries, and increased muscularization of the
small intra-acinar arterioles.10 Furthermore, the immuno-
histochemical staining of smooth muscle actin can be helpful
for evaluating the increased muscularity of pulmonary
arteries; whereas, the immunoreactivity of type IV collagen
can demonstrate the fibrotic changes in the alveolar septa
and common fibrous sheath.31 CD34 immunohistochemistry is
helpful in detecting the capillary apposition and density.32
Involvement of the lung may be diffuse (85% of cases) or
patchy (15%).11 ACD may occur with or without MLV,
depending on the stage of development during the anoma-
lies’ occurrence.17 Usui et al suggested the potential role of
diagnosis by prenatal fetal ultrasonography, which revealed
increasing lung echogenicity and polyhydramnios.33
The definite etiology of this anomaly is unknown. Failure
of formation and ingrowth of alveolar capillaries leading to
loss of normal air-blood barriers was proposed by Janney
et al.2 Genetic influences, mutation, or teratogenic expo-
sure in early pregnancy during embryogenesis may cause
pulmonary vasoconstriction that interrupts normal angio-
genesis.3,6,12,13,15,34 Vascular endothelial growth factors
have also been suggested.35 A review of pulmonary
pathology by deMello indicated that ACD probably reflects
a disorder of vasculogenesis, whereas MLV suggests
a disorder of sprouting or angiogenesis.36 Arterial muscu-
larization may be a primary anomaly or secondary to
hypoxemia induced by intrapulmonary shunting through the
arteriovenous wall.4 Wallot et al reported a case with
concurrent congenital alveolar proteinosis and MLV in
consanguineous infants. They speculated that mutations in
the surfactant protein B gene may influence vessel devel-
opment, leading to MLV.15 However, there is no evidence of
intrauterine infections or maternal distress related to ACD
and MLV.No specific treatment is available for ACD and MLV. The
goal of management is to reduce the severity of PPHN.
A review by Al-Hathlol et al indicated that tolazoline and
alkalosis with sodium bicarbonate achieved transient
improvement in PO2 in 50% and 20% of reported cases,
respectively, whereas prostaglandin E1 and E2, nitroprus-
side, diltiazem, dipyridamole, and magnesium sulfate
were not effective.11 Inhaled nitric oxide, high-frequency
oscillatory ventilation, and high-frequency jet ventilation
achieved only a transient response.11,22,37 Extracorporeal
membrane oxygenation was used in 41% of cases with MLV
and ACD, but all these patients were died after wean-
ing.11,23,38 Despite different strategies used for the
management of hypoxia and pulmonary hypertension in
cases of ACD and MLV reported in the literature, the
mortality rate in infancy was almost 100%.
ACD and MLV are rare causes of idiopathic PPHN. The low
rate of diagnosis may be because of the high mortality rate
or patchy involvement in some cases. We described the first
case of ACD and MLV without accompany anomaly, which
was confirmed by autopsy in Taiwan. The patient presented
as pneumothorax and severe idiopathic pulmonary hyper-
tension immediately after delivery. The patient’s condition
still deteriorated even though all the strategies for relieving
pneumothorax and PPHN. Increasing awareness of this
clinical entity may prevent the use of costly, invasive, and
probably ineffective procedures. Inhaled nitric oxide
therapy and extracorporeal membrane oxygenation merely
provide time for potential lung transplantation.References
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